LONDON--(BUSINESS WIRE)-- What are the precise gynecology rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? All these questions and many more hot issues are addressed in the report.
New research report “Gynecology Partnering Yearbook 2013” elaborated by CurrentPartnering provides an in-depth understanding and unprecedented access to gynecology partnering trends and structure of deals entered into by the world’s top healthcare companies during 2012, besides explaining how and why these companies enter these deals and agreements.
The partnering deals are listed by: company A-Z, headline value, stage of development at signing, deal component type, therapy area, and technology type.
Title: Gynecology Partnering Yearbook 2013
Published: January, 2013
Price: US$ 1,495.00
Other Healthcare Partnering Deals & Agreements Reports are Also Available:
More new research reports by CurrentPartnering can be found at http://marketpublishers.com/members/currentpartner/info.html
Source: The Market Publishers, Ltd.